Iovate claims upheld
This article was originally published in The Tan Sheet
Executive Summary
The Electronic Retailing Self-Regulation Program says July 18 Iovate Health Sciences' general product performance claims for its JointMD Joint Relief supplement are substantiated, but the firm must discontinue other claims. ESRP determines Mississauga, Ontario-based Iovate provides reasonable basis for its claims the product's primary ingredient begins working faster than glucosamine. However, Iovate's claims the product works 300% faster than maximum strength glucosamine must be discontinued. WellNx Life Sciences, a competing firm also based in Mississauga, challenged Iovate's claims in the self-regulatory forum...